SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-11-018945
Filing Date
2011-04-06
Accepted
2011-04-06 17:14:35
Documents
1
Period of Report
2011-04-06

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 10149
  Complete submission text file 0001104659-11-018945.txt   12252
Mailing Address
Business Address 2 GREENVILLE CROSSING 4005 KENNETT PIKE STE 220 GREENVILLE DE 19807
QUAKER BIO VENTURES LP (Reporting) CIK: 0001170144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 11743885

Mailing Address
Business Address 435 DOVER PARK DRIVE BLDG 500 WAYNE PA 19087 2159886811
QUAKER BIOVENTURES CAPITAL LP (Reporting) CIK: 0001223034 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 11743886

Mailing Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 919 313-4760
TRANZYME INC (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O QUAKER BIOVENTURES CIRCA CENTRE, 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address
Gavin Brenda D (Reporting) CIK: 0001488182 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 11743884